Skip to main content
Clinical Trials/JPRN-jRCTs051210034
JPRN-jRCTs051210034
Recruiting
未知

Clinical Trial for the Evaluation of Efficacy and Safety of Contrast Enhanced Ultrasonography-guided Sentinel Lymph Node Biopsy after Introducing Twirl Breast Marker for Axillary Lymph Node-positive Breast Cancer

Miyake Tomohiro0 sites20 target enrollmentJune 4, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Miyake Tomohiro
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Miyake Tomohiro

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients with the ability to consent who are 20 years old or older and younger than 90 years old at the time of obtaining informed consent
  • (2\) Clinically T1\-2N1M0 breast cancer patients with 1 to 2 positive axillary lymph nodes of whicn at least one axillary lymph node has been confirmed to harbor metastasis by fine needle aspiration cytology
  • (3\) Patients whose condition are expected to be stable for longer than 6 months at the time of obtaining the informed consent
  • (4\) Patients for whom a written consent has been obtained for participation in this study

Exclusion Criteria

  • (1\) Patients with palpable hard nodes
  • (2\) Patients with radiologically proven matted nodes or gross extranodal disease
  • (3\) Patients who have been treated with preoperative chemotherapy or hormonal therapy for breast cancer
  • (4\) Patients who are during or possibilities of pregnancy
  • (5\) Patients who are allergic to metal or egg
  • (6\) Patients with coronary artery disease
  • (7\) Patients who seem not eligible for the present study

Outcomes

Primary Outcomes

Not specified

Similar Trials